| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-08-12 | EBI-005 | moderate to severe allergic conjunctivitis |
3 | Eleven Biotherapeutics (USA - MA) | Allergic diseases - Immunological diseases - Ophtalmological diseases |
| 2015-08-10 | Iclusig® (ponatinib) | refractory, chronic-phase chronic myeloid leukemia (CP-CML) | 2 | Ariad Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2015-08-10 | ACP-01 (angiogenic cell precursors) | critical limb ischemia |
2 | Hemostemix (Canada - Israel) | Cardiovascular diseases |
| 2015-08-10 | AGS-003 | renal cell carcinoma |
Argos Therapeutics (USA - NC) | Cancer - Oncology | |
| 2015-08-10 | RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) | Respiratory Syncytial Virus (RSV) infection | 2 | Novavax (USA - MD) | Infectious diseases |
| 2015-08-10 | NiCord® | hematological cancers | 3 | Gamida Cells (Israel) | Cancer - Oncology |
| 2015-08-07 | sublingual immunotherapy tablet (SLIT-tablet) | Japanese cedar tree pollen allergy |
2-3 | ALK Abello (Denmark) Torii Pharmaceutical (Japan) | Allergic diseases - Immunological diseases |
| 2015-08-06 | IGN002 | non-Hodgkin lymphoma (NHL) |
1 | Valor Biotherapeutics (USA - TX) | Cancer - Oncology |
| 2015-08-06 | VTS-270 | Niemann-Pick disease type C | 1 | Vtesse (USA - MD) | Rare diseases - Genetic diseases |
| 2015-08-06 | PEGPH20 | pancreatic cancer | 2 | Halozyme Therapeutics (USA - CA) Pancreas Center at the University of California, San Francisco (UCSF) (USA - CA) | Cancer - Oncology |
| 2015-08-06 | Nuplazid™ (pimavanserin) | psychosis associated with Parkinson’s disease | 3 | Acadia Pharmaceuticals (USA - CA) | Neurodegenerative diseases - Psychiatric diseases - Mental diseases |
| 2015-08-06 | ATX-MS-1467/M2736 | multiple sclerosis | 2 | Merck KGaA (Germany) | Neurodegenerative diseases |
| 2015-08-05 | PRO 140 | HIV infection |
3 | CytoDyn (Canada) | Infectious diseases |
| 2015-08-05 | recombinant human beta-glucuronidase (rhGUS, UX003) | mucopolysaccharidosis 7 (MPS 7, Sly syndrome) |
2 | Ultragenyx Pharmaceutical (USA - CA) | Rare diseases - Genetic diseases - Metabolic diseases |
| 2015-08-05 | urelumab (BMS-663513) | malignant tumors | 1 | BMS (USA - NY) Ono Pharmaceutical (Japan) | Cancer - Oncology |
| 2015-08-04 | ALLN-177 | secondary hyperoxaluria |
2b | Allena Pharmaceuticals (USA - MA) | Rare diseases - Metabolic diseases |
| 2015-08-04 | sparsentan (RE-021) | focal segmental glomerulosclerosis | 2 | Retrophin (USA - CA) | Rare diseases |
| 2015-08-03 | PRX-106 (biosimilar version of etanercept) | immune mediated disorders | 1 | Protalix BioTherapeutics (Israel) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2015-08-03 | Kynamro® (mipomersen sodium) | severe heterozygous familial hypercholesterolemia (severe HeFH) |
3 | Isis Pharmaceuticals (USA - CA) | Cardiovascular diseases - Genetic diseases |
| 2015-08-03 | simeprevir, odalasvir (ACH-3102) and AL-335 | chronic hepatitis C | 1 | Alios Biopharma, a J&J company (USA - NJ) Achillion Pharmaceuticals (USA - CT) | Infectious diseases |
